Mount Sinai's AI-powered ECG tool now predicts individual risk for hypertrophic cardiomyopathy (HCM), enabling faster ...

Researchers have calibrated an AI algorithm to more specifically identify patients with hypertrophic cardiomyopathy (HCM), a ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an ...

As Gov. Maura Healey embraced 5-year-old Lincoln, his mother sobbed and explained that the boy had just received a heart ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an ...

An Israeli study has identified TRIM63 as a significant genetic contributor to hypertrophic cardiomyopathy (HCM)—the most ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

Cobenfy’s late-stage flop is BMS’ second high-profile failure in as many weeks. The pharma announced last week that Camzyos ...

Tenaya Therapeutics (TNYA) announced interim data from its ongoing RIDGE natural history and seroprevalence study of adults with arrhythmogenic ...

Cytokinetics, Incorporated’s CYTK share price has surged by 5.04%, which has investors questioning if this is right time to sell.

Barclays analyst Gena Wang initiated coverage of Cytokinetics (CYTK) with an Overweight rating and $55 price target The firm says the company ...

Better emergency action plans implemented by race organizers are keeping more runners who experience a heart attack alive, ...